KR101797780B1 - 반고체 조성물 및 약제학적 제품 - Google Patents

반고체 조성물 및 약제학적 제품 Download PDF

Info

Publication number
KR101797780B1
KR101797780B1 KR1020127000600A KR20127000600A KR101797780B1 KR 101797780 B1 KR101797780 B1 KR 101797780B1 KR 1020127000600 A KR1020127000600 A KR 1020127000600A KR 20127000600 A KR20127000600 A KR 20127000600A KR 101797780 B1 KR101797780 B1 KR 101797780B1
Authority
KR
South Korea
Prior art keywords
semi
triglycerides
ala
delete delete
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127000600A
Other languages
English (en)
Korean (ko)
Other versions
KR20120046155A (ko
Inventor
그라이 스텐스러드
Original Assignee
포토큐어 에이에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 포토큐어 에이에스에이 filed Critical 포토큐어 에이에스에이
Publication of KR20120046155A publication Critical patent/KR20120046155A/ko
Application granted granted Critical
Publication of KR101797780B1 publication Critical patent/KR101797780B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020127000600A 2009-06-11 2010-06-11 반고체 조성물 및 약제학적 제품 Active KR101797780B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09251537 2009-06-11
EP09251537.8 2009-06-11
PCT/EP2010/003532 WO2010142457A1 (en) 2009-06-11 2010-06-11 Semi-solid compositions and pharmaceutical products

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020177027346A Division KR20170116198A (ko) 2009-06-11 2010-06-11 반고체 조성물 및 약제학적 제품

Publications (2)

Publication Number Publication Date
KR20120046155A KR20120046155A (ko) 2012-05-09
KR101797780B1 true KR101797780B1 (ko) 2017-11-14

Family

ID=41213323

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020127000600A Active KR101797780B1 (ko) 2009-06-11 2010-06-11 반고체 조성물 및 약제학적 제품
KR1020177027346A Ceased KR20170116198A (ko) 2009-06-11 2010-06-11 반고체 조성물 및 약제학적 제품

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020177027346A Ceased KR20170116198A (ko) 2009-06-11 2010-06-11 반고체 조성물 및 약제학적 제품

Country Status (19)

Country Link
US (2) US20120136055A1 (https=)
EP (2) EP2440199B1 (https=)
JP (1) JP5840604B2 (https=)
KR (2) KR101797780B1 (https=)
CN (1) CN102458388B (https=)
AU (1) AU2010257753B2 (https=)
CA (1) CA2763923C (https=)
CL (1) CL2011003094A1 (https=)
DK (1) DK2440199T3 (https=)
ES (2) ES2821831T3 (https=)
HU (1) HUE026911T2 (https=)
MX (1) MX2011013127A (https=)
NZ (1) NZ596943A (https=)
PL (1) PL2440199T3 (https=)
RU (1) RU2526803C2 (https=)
SG (1) SG176688A1 (https=)
SI (1) SI2440199T1 (https=)
WO (1) WO2010142457A1 (https=)
ZA (1) ZA201109126B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
CN102670577B (zh) * 2012-05-18 2018-04-13 上海复旦张江生物医药股份有限公司 一种光敏剂组合物、其使用方法及用途
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
JP6363115B2 (ja) * 2013-02-28 2018-07-25 ミラ ファーマ コーポレイション 注射可能局所麻酔半固体製剤およびその組成物
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
AU2015253045B2 (en) * 2014-04-30 2020-07-16 Allergan, Inc. Formulations of biologics for intravesical instillation
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
BR112018011965A2 (pt) 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
WO2017168416A1 (en) * 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
US11884784B2 (en) 2016-05-10 2024-01-30 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
WO2017196961A1 (en) * 2016-05-10 2017-11-16 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
EP4299395B1 (en) * 2017-05-01 2025-10-15 Cummins, Inc. System and method for controlling energy generation in a hybrid powertrain
DK3641882T3 (da) * 2017-06-21 2023-12-18 Photocure Asa Fremgangsmåde til fremstilling af en flydende farmaceutisk sammensætning og indretning til anvendelse i en sådan fremgangsmåde
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
GB201808571D0 (en) * 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Pharmaceutical compositions
EP3846852A4 (en) 2018-09-07 2022-06-15 R.P. Scherer Technologies, LLC Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)
IL285384B2 (en) 2019-02-13 2024-11-01 Alpheus Medical Inc Non-invasive sonodynamic therapy
MX2021014512A (es) 2019-05-29 2022-02-11 Sonalasense Inc Sonosensibilizacion.
CN110575612A (zh) * 2019-09-27 2019-12-17 赵志国 女用光动力凝胶封包敷料装置
WO2022032283A2 (en) 2020-08-07 2022-02-10 Alpheus Medical, Inc. Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
TW202600126A (zh) * 2024-03-12 2026-01-01 大陸商上海亞虹醫藥科技有限公司 用於子宮頸疾病或病症之光動力療法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JPH08175986A (ja) * 1994-09-20 1996-07-09 Johnson & Johnson Medical Inc 経皮活性を示す５−アミノレブリン酸含有薬学組成物
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
ATE202076T1 (de) 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
EP0844876A4 (en) * 1995-08-14 1999-12-01 Univ California ENDOMETRIAL ABLATION USING PHOTODYNAMIC TREATMENT WITH GREEN PORPHYRINS
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
US20020132035A1 (en) * 2001-01-10 2002-09-19 Dov Tamarkin Synthetic fat composition
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
EP1312353A1 (en) 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device

Also Published As

Publication number Publication date
EP3042647A1 (en) 2016-07-13
AU2010257753A1 (en) 2012-01-12
CA2763923C (en) 2016-09-13
CN102458388A (zh) 2012-05-16
CA2763923A1 (en) 2010-12-16
RU2526803C2 (ru) 2014-08-27
KR20170116198A (ko) 2017-10-18
CL2011003094A1 (es) 2012-07-20
MX2011013127A (es) 2012-02-21
JP5840604B2 (ja) 2016-01-06
NZ596943A (en) 2013-09-27
WO2010142457A1 (en) 2010-12-16
HUE026911T2 (en) 2016-07-28
AU2010257753B2 (en) 2014-09-18
KR20120046155A (ko) 2012-05-09
EP2440199B1 (en) 2016-04-13
ES2821831T3 (es) 2021-04-27
SI2440199T1 (sl) 2016-05-31
JP2012529452A (ja) 2012-11-22
US20150238457A1 (en) 2015-08-27
BRPI1010761A2 (pt) 2016-03-22
PL2440199T3 (pl) 2016-10-31
EP2440199A1 (en) 2012-04-18
US20120136055A1 (en) 2012-05-31
EP3042647B1 (en) 2020-08-26
ZA201109126B (en) 2013-02-27
SG176688A1 (en) 2012-01-30
CN102458388B (zh) 2016-09-28
DK2440199T3 (en) 2016-05-17
HK1164163A1 (zh) 2012-09-21
RU2011150919A (ru) 2013-07-20
ES2573085T3 (es) 2016-06-06
US9326964B2 (en) 2016-05-03

Similar Documents

Publication Publication Date Title
KR101797780B1 (ko) 반고체 조성물 및 약제학적 제품
JP5686603B2 (ja) 使用
AU2010257752B2 (en) Solid compositions comprising 5-aminolevulinic acid
KR101842732B1 (ko) 광역동 치료 또는 광역동 진단에 사용하기 위한 건조 조성물 및 이와 같은 건조 조성물을 포함하는 기구
AU2009331842A1 (en) Enema preparations and their use
BRPI1010761B1 (pt) Composição semissólida, kit e seu uso dos mesmos
HK1164163B (en) Semi-solid compositions and pharmaceutical products
Shruti et al. Innovative Approach to Endometriosis: Nanotechnology
GB2546128A (en) Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
AU2014200004B2 (en) Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120109

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150611

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160922

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20170627

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20160922

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20170926

PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20170627

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20170214

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20150611

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20171031

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20170926

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20170627

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20170214

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20150611

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20171108

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20171108

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20201029

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20201029

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20211027

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20211027

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20221025

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20221025

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20231026

Start annual number: 7

End annual number: 7